Amgen Inc.AMGNNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+9.2%
5Y CAGR+4.0%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+9.2%/yr
vs -1.4%/yr prior
5Y CAGR
+4.0%/yr
Recent acceleration
Acceleration
+10.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.84B | +18.6% |
| 2024 | $13.36B | -9.8% |
| 2023 | $14.80B | +21.6% |
| 2022 | $12.17B | +7.7% |
| 2021 | $11.30B | -13.1% |
| 2020 | $13.00B | +2.9% |
| 2019 | $12.63B | -1.9% |
| 2018 | $12.88B | +0.2% |
| 2017 | $12.86B | +2.6% |
| 2016 | $12.53B | - |